Summary: Transforming growth factor-a (TOF-a) is a ligand for the epidermal growth factor (EO F) receptor (EOFR), and is more abundant than EOF in the brain. The authors studied whether administration of exogenous TOF-a into the brain can protect neurons against ischemia in a model of permanent middle cerebral artery (MCA) occlusion in the rat, and whether any effect of TOF-a was mediated by EOFR by administering 4,5-dianilinophthalimide (DAPH), a protein-tyrosine kinase in hibitor with high selectivity for EOFR. Rats received either TOF-a (10 or 25 ng), DAPH (100 ng), DAPH plus TOF-a (25 ng), or vehicle in the ipsilateral first ventricle. Drugs were administered twice: 30 minutes before and 30 minutes after Administration of exogenous growth factors, such as brain-derived neurotrophic factor acting through the high-affinity receptor tyrosine kinase, TrkB (Schabitz et aI., 1997), and ciliary neurotrophic factor (Kumon et aI., 1996), can protect the brain against focal ischemia. Like wise, many growth factors have been shown to exert a protective effect in transient forebrain ischemia. In this latter condition, it has recently been reported that epider mal growth factor (EGF) protects neuronal cells (Peng et aI., 1998). Here we examined whether exogenous trans forming growth factor-a (TGF-a), a growth factor that binds the EGF receptor (EGFR), was able to exert any protective effect in a model of permanent focal ischemia in the rat, and whether EGFR activation was involved.
MCA occlusion, and infarct volume was evaluated 24 hours later. Transforming growth factor-a at the dose of 25 ng caused a statistically significant reduction of infarct volume (60%) in relation to ischemic rats administered vehicle. This reduction was no longer seen when TOF-a was administered in combi nation with DAPH. The present results show that TOF-a can protect neurons from ischemic damage, and that this effect is mediated by EOFR. It is suggested that activation of EOFR mediated intracellular signalling pathways contributes to the survival of neural cells susceptible to ischemic injury. Key Words: Stroke-Neuroprotection-Tyrosine kinase-4,5-Dianilinophthalimide-Brain.
showing 35% homology to EGF (Marquardt et aI., 1983) . Transforming growth factor-a also mediates its biologi cal activity upon binding the EGFR with high affinity, induces tyrosine phosphorylation of the receptor, and has strong mitogenic activity for epithelial and mesenchimal cells (Massague, 1983; Reynols et aI., 1983; Derynck, 1988) . Both TGF-a and EGF are constitutively ex pressed in the developing and adult brain (Kudlow et aI., 1989; Kaser et aI., 1992; Lazar and Blum, 1992; Ma et aI., 1992; Seroogy et aI., 1993; Ferrer et aI., 1995 Ferrer et aI., ,1996 , although TGF-a is more abundant than EGF in the eNS (Lazar and Blum, 1992; Kaser et aI., 1992; Seroogy et aI., 1993) . In the adult brain under physiologic condi tions, TGF-a is found in neurons and some glial cells (Seroogy et aI., 1993; Ferrer et aI., 1995 Ferrer et aI., , 1996 , whereas EGFR is essentially located in neurons (Gomez-Pinilla et aI., 1988; Kaser et aI., 1992; Kornblum et aI., 1995; Ferrer et aI., 1996 , Planas et aI., 1998 . However, EGFR is highly induced under conditions involving glial reac tivity (Gomez-Pinilla et aI., 1988; Nieto-Sampedro et aI., 1988; Ferrer et aI., 1996) . In particular, EGFR is ex pressed in reactive astrocytes and microglial macrophages after transient focal ischemia in the rat brain (Planas et aI., 1998) . Today, the role and mecha-nism of action of TGF-a and EGFR in neural cells re mains to be clarified. Transforming growth factor-a is a soluble factor that is released through enzymatic cleav age from a larger precursor protein anchored in the cell membrane (Massague, 1990; Derynck, 1992) . Trans forming growth factor-a released to the extracellular space as a soluble factor is bioactive by acting on the membrane-bound EGFR, causing paracrine stimulation. An autocrine stimulation is also feasible, because TGF-a and EGFR colocalize in many neurons (FeHer et aI., 1996) . In addition, several lines of evidence suggest that noncleaved, pro-TGF-a interacts with EGFR on a neigh boring adjacent cell, or the same cell, and exerts a jux tacrine effect (Wong et aI., 1989; Anklesaria et aI., 1990; Massague et aI., 1990) . Exogenous TGF-a administered into the brain would be expected to diffuse and act on membrane-bound EGFR. This mode of action would mimic, to some extent, paracrine stimulation of EGFR by endogenous soluble TGF-a.
METHODS

Rats and Surgery
Adult male Sprague-Dawley rats (280 to 320 g body weight) obtained from Iffa-Credo (Lyon, France) were kept under a 12-hour light-dark cycle and allowed free access to food and water. Animal work was conducted in compliance with the Spanish legislation on "Protection of Animals used for Experi mental and other Scientific Purposes", and in accordance with the Directives of the European Community on this subject. Surgery was performed under halothane anesthesia. One day before ischemia, guide cannulae were implanted stereotaxically into the ipsilateral ventricle at the following coordinates: 0.3 mm posterior, 1.2 mm lateral, 3.2 mm ventral to bregma (Paxi nos and Watson, 1986) . Focal cerebral ischemia was produced by intraluminal occlusion of the middle cerebral artery (MCA) following the method of Longa et al. (1989) , with modifica tions (as in our case MCA occlusion was permanent). Briefly, rats were anesthetized with halothane, tracheotomized orally, and kept ventilated. Body temperature was maintained at 37.5°C during surgery. Permanent ischemia was produced by introducing a 26-mm long, 3/0 nylon monofilament, blunted at the tip, through the internal carotid artery to the level where the MCA branches out. After surgery, rats were allowed to recover spontaneous breathing and were kept for 24 hours in their cages with free access to food and water. Rats were killed at 24 hours after MCA occlusion, the brain was rapidly frozen, and 20 fl,m-thick coronal sections were cut in a cryostat. Sections col lected at I-mm intervals were stained with cresyl violet for image analysis.
Drugs and Treatments
Human recombinant TGF-a (Oncogene Science Calbio chern, AMS Biotechnology, Madrid, Spain) was prepared following the instructions of the manufacturer, and finally dissolved in 0.1 M phosphate-buffered saline yielding pH 7. Phosphate-buffered saline was administered as the vehicle solution in the control group. The EGFR inhibitor 4,5-dianilinophthalimide (DAPH) was purchased from RBI (KOln, Germany), and was dissolved in phosphate-buffered saline. Rats were given vehicle (phosphate-buffered saline) (n = 7), 10 ng TGF-a (n = 7), 25 ng TGF-a (n = 7), 100 ng DAPH and 25 ng TGF-a (n = 5), and 100 ng DAPH (n = 6). Treatments were administered into the ipsilateral ventricle twice: 30 minutes before and 30 minutes after MCA occlusion.
Evaluation of infarct volume
Infarct volume was evaluated by means of an image analyz ing system (AIM, Image Research, Canada). The whole area of infarct, which at 24 hours is apparent by marked pallor in cresyl violet stained sections, was measured in each section, and then data from all sections were integrated. In addition, contralateral and ipsilateral hemisphere areas were measured, and the dif ference between ipsilateral and contralateral areas in each sec tion was used to calculate the volume of brain swelling. Mea sures were performed by one of the authors who was blind to the treatment of each particular rat. Statistical analysis of data was performed using Mann-Whitney U-test, a nonparametric test for comparison of mean group values. The relationship between the two parameters that were calculated for each rat, i.e. infarct volume and volume of swelling, was evaluated with simple regression analysis.
RESULTS
Rats were randomly assigned to one of the following treatment groups: control (vehicle), lOng TGF-a, 25 ng TGF-a, 25 ng TGF-a plus DAPH, and DAPH. Treat ment was administered to the right ventricle 30 minutes before and 30 minutes after permanent occlusion of the ipsilateral MCA. No differences in behavior were ob served between groups. Infarct volume was evaluated at 24 hours. Infarct affected the ipsilateral cortex and stria tum, although rats receiving 25 ng TGF-a showed com paratively smaller infarcts, especially in the cortex. This latter effect was no longer observed after administration of TGF-a plus DAPH. Infarct volume was calculated by measuring infarct area in serial coronal sections and then integrating all measures. Statistical comparison of data demonstrated that rats administered 25 ng TGF-a had infarcts that were 60% smaller than controls (P < 0.02) (Fig. 1) . Also, rats receiving the dose of lOng TGF-a showed a mean infarct volume 30% smaller than that of controls ( Fig. 1 ), but this effect was not statistically sig nificant. The protective effect of 25 ng TGF-a was elimi nated by coadministration of TGF-a plus the EGFR pro tein-tyrosine kinase inhibitor DAPH (Fig. 1) . Compari son of infarct volume between rats administered 25 ng TGF-a and those receiving 25 ng TGF-a plus DAPH showed significant differences (P < 0.02). Rats given DAPH showed no differences in relation to controls (Fig. 1 ).
An index of the extent of edema in terms of volume of swelling (mm 3 ) was calculated by measuring for each section the area of the whole ipsilateral and contralateral hemispheres, then subtracting the contralateral from the ipsilateral brain side, and integrating areas. The ipsilat eral ischemic hemisphere was larger than the contralat eral for all groups (Fig. 1) , indicating that quite large edemas had been formed within 24 hours of permanent occlusion of the MCA. However, less swelling than con- (7) (7) (7) DAPH. Infarct volume in the T25 group was found to be significantly smaller than that in controls (**, P < 0.02) showing that TGF-a had a protective effect. This effect was eliminated after coadministration of TGF-a and DAPH (P < 0.02). Volume of swelling decreased in T1 0 (*, P < 0.05) and T25 (***, P < 0.005) groups in relation to controls. The effect of T25 was no longer seen when this was administered in combination with DAPH (P < 0.01). Number of rats is shown in brackets below each group. DAPH, 4,5-dianilinophthalimide; TGF-a, transforming growth factor-a.
troIs was detected in the two groups of rats receiving TOF-a. Swelling was reduced by 36 % (P < 0.05) and 64% (P < 0.005) in rats receiving 10 and 25 ng, respec tively. The effect of 25 ng TOF-a on brain swelling was also eliminated by coadministration of DAPH (P < 0.001) (Fig. 1) . Linear regression analysis considering all rats showed a significant linear correlation (P < 0.001, r = 0.95, slope = 0.463) indicating proportionality be tween infarct volume and volume of swelling (Fig. 2) . Significant correlation between these two parameters was also found within each treatment group (P < 0.01). 
DISCUSSION
Orowth factors promote growth and differentiation of cells in culture, and many previous studies have shown that administration of different trophic factors can offer protection to the brain against ' ischemic injury (e.g., Ku mon et aI., 1996; Schabitz et aI., 1997). Here we studied the effect of intraventricular administration of TOF-a to rats subjected to permanent MCA occlusion. Transform ing growth factor-a reduced infarct volume to 60% of that of ischemic controls at 24 hours after permanent occlusion of the MCA. Transforming growth factor-a is a ligand for EOFR, a membrane receptor with intrinsic tyrosine kinase activity. We have inhibited EOFR pro tein-tyrosine kinase with a drug, DAPH, that is highly selective toward EOFR (Buchdunger et aI., 1994; Furet et aI., 1995; Yen and Scoong, 1996) . The results show that the reduction of infarct volume caused by 25 ng TOF-a is completely eliminated when TOF-a is admin istered in combination with DAPH. This strongly sug gests that the protective effect of TOF-a is mediated by EOFR. In parallel to reducing infarct volume, TOF-a caused a dose-dependent decrease in brain swelling. Swelling and infarct volumes were strongly correlated, showing that the extent of swelling is proportional to the extent of infarction, as previously observed (Jacewicz et aI., 1990; Kusumoto et aI., 1992) .
The present results are in agreement with a recent study showing that intraventricular infusion of EOF in the gerbil protects hippocampal neurons against isch emia, possibly through inhibition of free radical neuro toxicity and lipid peroxidation (Peng et aI., 1998) . Trans forming growth factor-a has also been shown to protect striatal neurons against excitotoxic injury induced by quinolinic acid (Alexi et aI., 1997) . Also, an EOFR-dependent pathway is involved in the protective effect of chromaffin granules on mesencephalic dopaminergic neurons (Krieglstein and Un sicker, 1997) . Other studies have concluded that TGF-a acts as a general neuronal survival factor, affecting cholinergic and GABAergic neurons (Mazzoni and Kenigsberg, 1996) . Transforming growth factor-a is normally expressed in neurons and glia of the adult brain (Ferrer et aI., 1995) , but whether basal TGF-a can exert any neuroprotective effect in isch emia is unknown. Here, DAPH, which is expected to prevent effects of basal TGF-a, did not produce any substantial modification of infarct volume in relation to controls. Nevertheless, loss of basal TGF-a has been detected within the ischemic area at 6 hours after MCA occlusion (Ferrer et aI., 1996) . This would hamper TGF a-dependent neuroprotective action after ischemia, and thus prevent DAPH from exacerbating ischemic damage. However, the possibility that increases in infarct volume were not detected here cannot be ruled out because con trols already show very large infarct volumes.
Epidermal growth factor receptor is expressed in neu rons and glial cells in the developing brain, and mainly in neurons in the adult brain (G6mez-Pinilla et aI., 1988; Kaser et aI., 1992; Kornblum et aI., 1995; Ferrer et aI., 1996 , Planas et aI., 1998 . After transient MCA occlu sion, EGFR is highly induced in reactive astrocytes and microglia/macrophages by 3 to 4 days after ischemia (Planas et aI., 1998) . After permanent MCA occlusion, the first signs of glial reactivity (i.e. increase in glial fibrillary acidic protein indicating astrogliosis, and neu trophil infiltration) are seen at 12 hours (Clark et aI., 1994) . Therefore, exogenous TGF-a administered in this study probably acts on neuronal membrane-anchored EGFR because neuronal protection must take place dur ing the first hours after MCA occlusion before marked glial reactivity is apparent. Neurons within the MCA territory, i.e. lateral cortex and striatum, are rich in EGFR (Planas et aI., 1998) , and are thus susceptible to the action of exogenous TGF-a. Ligand-binding to EGFR can activate intracellular signal transduction path ways involving proteins of the family of signal tranduc ers and activators of transcription (STATs) (Darnell et aI., 1994; Ruff-Jamison et aI., 1994; Ihle, 1996) . On stimulation, ST A Ts can translocate to the nucleus and activate transcription, thus mediating a cellular response to changes in the environment. We have previously re ported the presence of STAT proteins in the developing and adult rat brain (Planas et aI., 1996; 1997 a,b) . Wheth er or not STAT proteins become activated after stimula tion of the EGFR by exogenous TGF-a and mediate neuronal protection remains to be established.
In brief, the present results show that TGF-a can pro tect neurons from ischemic damage and that this effect is mediated by EGFR. It is suggested that activation of EGFR-mediated intracellular signaling pathways promotes survival of neural cells susceptible to ischemic injury.
